Consequently, WDR5 is recruited by different RNA‐binding proteins and lncRNAs to the promoter region of the downstream targets, thereby enabling H3K4me3 modification and transcriptional activation in varying inflammatory diseases, including liver fibrosis and Alzheimer's disease [30, 31]. Here, WDR5 is linked to early-onset autosomal dominant Alzheimer disease.